Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;35(5):313.
doi: 10.5581/1516-8484.20130101.

Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years

Sergio Paulo Bydlowski  1
Affiliations

Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years

Sergio Paulo Bydlowski. Rev Bras Hematol Hemoter. 2013.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interest

Comment on

  • Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. :352–357.

References

    1. Ruiz MA, Bydlowski SP, Seber A. Cell therapy is a medicine of the future? Rev Bras Hematol Hemoter. 2009;31(Supl 1):1.
    1. Bydlowski SP, Debes AA, Maselli LM, Janz FL. Biological characteristics of mesenchymal stem cells. Rev Bras Hematol Hemoter. 2009;31(Supl 1):25–35.
    1. Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85(1):3–10. - PubMed
    1. Ardhanareeswaran K, Mirotsou M. Lung stem and progenitor cells. Respiration. 2013;85(2):89–95. - PMC - PubMed
    1. Kubo H. Concise review: clinical prospects for treating chronic obstructive pulmonary disease with regenerative approaches. Stem Cells Transl Med. 2012;1(8):627–631. - PMC - PubMed

LinkOut - more resources